» Articles » PMID: 19948632

The Role of Immunoprophylaxis in the Reduction of Disease Attributable to Respiratory Syncytial Virus

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2009 Dec 2
PMID 19948632
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.

Blanken M, Koffijberg H, Nibbelke E, Rovers M, Bont L PLoS One. 2013; 8(3):e59161.

PMID: 23554987 PMC: 3595233. DOI: 10.1371/journal.pone.0059161.


Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis.

Smith S, Dampier W, Tozeren A, Brown J, Magid-Slav M PLoS One. 2012; 7(3):e33174.

PMID: 22432004 PMC: 3303816. DOI: 10.1371/journal.pone.0033174.


The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Bradley J, Byington C, Shah S, Alverson B, Carter E, Harrison C Clin Infect Dis. 2011; 53(7):e25-76.

PMID: 21880587 PMC: 7107838. DOI: 10.1093/cid/cir531.


Detection of respiratory syncytial virus using nanoparticle amplified immuno-polymerase chain reaction.

Perez J, Vargis E, Russ P, Haselton F, Wright D Anal Biochem. 2010; 410(1):141-8.

PMID: 21111702 PMC: 4208676. DOI: 10.1016/j.ab.2010.11.033.


Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target.

Mukherjee S, Lukacs N Expert Rev Anti Infect Ther. 2010; 8(6):617-21.

PMID: 20521887 PMC: 2955489. DOI: 10.1586/eri.10.39.